LEM-14-1189 B
Lem-14-1189, a LEM-14 derivative, is a potent NSD inhibitor of the nuclear receptor binding SET domain, and has inhibitory effects on NSD1, NSD2, and NSD3, with IC50 of 418 μM, 111 μM, and 60 μM, respectively. LEM-14-1189 has potential anticancer activity and can be used to study multiple myeloma (MM) and diseases of the blood system.
Product Specifications
CAS Number
2987501-17-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
682.81
Molecular Formula
C35H34N6O5S2
Notes
Research use only, not for human use.
Receptor
Histone Methyltransferase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPC30548-01 20 µg
Recombinant Rat Gastric inhibitory polypeptide receptor (Gipr), partial , Active Protein
Ask
View Details 
RPC30548-02 100 µg
Recombinant Rat Gastric inhibitory polypeptide receptor (Gipr), partial , Active Protein
Ask
View Details 
RPC30548-03 1 mg
Recombinant Rat Gastric inhibitory polypeptide receptor (Gipr), partial , Active Protein
Ask
View Details